No ATM carriers were detected by p53-MCL in patients with ovarian cancer, bilateral breast cancer, or multiple cancers (breast cancer and at least one other non-breast cancer) (n = 27) (Table 3). This evidence concerns the gene TP53 and breast carcinoma.